Litcius/Paper detail

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

Zachary E. Holcomb, Monica Rosales Santillan, Peyton Morss, Prerna Salian, Min Ji Her, Nicole M. Giannotti, Alexa B. Kimball, Martina L. Porter

2020Journal of the American Academy of Dermatology23 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyTerm (time)MEDLINEBetacoronavirusIntensive care medicineVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakQuantum mechanicsLawPhysicsPolitical sciencePsoriasis: Treatment and PathogenesisDermatological and COVID-19 studiesCOVID-19 Clinical Research Studies
Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy | Litcius